INVIVO THERAPEUTICS HOLDING CORP | SC 13G/A:超过5%持股股东披露文件(修正)-Armistice Capital, LLC(4.99%),Steven Boyd(4.99%)
INVIVO THERAPEUTICS HOLDING CORP | SC 13G/A:超过5%持股股东披露文件(修正)-Lind Global Macro Fund, LP(3.9%),Lind Global Partners LLC(3.9%)等
Invivo Therapeutics | 4/A:持股变动声明(修正)-股东 Foose Brice
Invivo Therapeutics | 4:持股变动声明-股东 Foose Brice
Invivo Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Brice Foose(0%)
Invivo Therapeutics | SC 13G:超过5%持股股东披露文件-Brice Foose(11.5%)
Invivo Therapeutics | 3:首次持股声明-股东 Foose Brice
Invivo Therapeutics | SC 13G:超过5%持股股东披露文件-Armistice Capital, LLC(9.99%),Steven Boyd(9.99%)
Invivo Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Lind Global Macro Fund, LP(6.3%),Lind Global Partners LLC(6.3%)等
Invivo Therapeutics | 4:持股变动声明
Invivo Therapeutics | 4:持股变动声明
Invivo Therapeutics | 4:持股变动声明
Invivo Therapeutics | 4:持股变动声明
Invivo Therapeutics | 4:持股变动声明
Invivo Therapeutics | 4:持股变动声明
Invivo Therapeutics | 4:持股变动声明
Invivo Therapeutics | 4:持股变动声明
Invivo Therapeutics | D:发行公告
Invivo Therapeutics | 3:首次持股声明-高管 Hamel Heather
Invivo Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Mitchell P. Kopin(2.5%),Daniel B. Asher(2.5%)等